H.C. Wainwright raised the firm’s price target on Ligand (LGND) to $157 from $144 and keeps a Buy rating on the shares ahead of the Q3 report. The firm updated Ligand’s valuation based on recent deals. It is “looking for continued ramp of smart deals.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGND: